The COVAX plan hopes to provide immunizations to 20% of the world’s population in 2021, especially those countries with fewer resources, to end the acute phase of the pandemic.
March marked the first anniversary of the pandemic that completely changed our daily lives.We are still in trouble, only if we have Vaccines and specific treatments against covid-19 that everyone can use. In this way, the restrictions that have marked our lives in the past year can be lifted.
During this time, we had to deal with a lot challenge.
first of all, Develop a vaccine catalog in record timeThis is a challenge completed in less than a year, and this process usually takes decades. This is an unprecedented milestone. The science has been delivered, and to a large extent, we owe it to the vigorous mobilization of public and private economic resources to achieve this common goal. This is the important first lesson: Science investment is essential Be prepared and able to deal with such threats, as science itself warns us, because of the loss of biodiversity and the climate crisis, such threats will become more frequent.
under these circumstances, COVAX Initiative Created to face the second great challenge: Ensuring fair immunity At least 20% of the population of all countries, including those with medium and scarce resources, will allow the end of the acute phase of the influenza pandemic by the end of 2021. However, unlike the previous view, in this case, we still have a long way to go to overcome the challenge.Although it is certain that by the end of this year, we will be able to overcome The threshold of 20% of the world’s immunized populationThis will be mainly concentrated in countries with the most resources, while in countries with medium and scarce resources, this number is likely to lag far behind.
European countries, the United Kingdom, Canada, the United States and Japan have reached a bilateral agreement with the pharmaceutical industry to immunize their entire population several times
Why create a mechanism To thisLooks like we are about to achieve our goal?Despite supporting the initiative, European Union, United Kingdom, Canada, United States ÿ Japan They have reached a bilateral agreement with the pharmaceutical industry to purchase many doses of vaccines so that they can immunize the entire population multiple times. Therefore, when vaccine production started three months ago, these countries were the first to receive vaccines and launch vaccination campaigns. For example, Spain, which purchased vaccines through negotiations and agreements with the European Commission, has received more than 15 million doses of different vaccines, which makes it possible to vaccinate more than 145,000 people with at least one dose. At the end of December.
At the same time, COVAX has just started distributing vaccines to low- and middle-income countries a few days ago, marking an important milestone for the vaccine. The global fight against covid-19.
A few days ago, COVAX just started distributing vaccines to low- and middle-income countries, which marked an important milestone in the fight against covid-19.
COVAX is made by Two great tools. A country designed for high-income people-the first country to obtain and own a vaccine and the private and charitable sectors-a way to donate for the purchase and distribution of vaccines. 92 low- and middle-income countries Otherwise you will not be able to access them.Another plan The remaining 50 countries, The purchase of its vaccines has been mediated by COVAX, which has increased the need to improve negotiation conditions with the industry.
When this mechanism was designed last spring, it has become The world’s best vaccine purchasing tool.However, in the end, this desire was restricted and eventually became Main hope Applicable to many middle-income countries, especially Latin America, these countries rely on their own resources to obtain vaccines in the near future, and thanks to COVAX, these countries have been able to obtain better negotiation conditions with the industry.
If COVAX cannot be the global access tool it aspires to be, it is because the wealthiest countries most capable of negotiating with the industry have put their immunizations ahead of the global response that the initiative wants to represent. We will have to wait until the end of 2021 to see how far we are from overcoming the fair challenges set as goals.
Virginia Rodríguez Bartolomé (Virginia Rodríguez Bartolomé) She is responsible for the advocacy project of the Barcelona Institute of Global Health (ISGlobal).